Sunshine Lake Pharma Co., Ltd. (HKG:6887)
36.96
+0.38 (1.04%)
Sep 11, 2026, 4:08 PM HKT
Sunshine Lake Pharma Market Cap
Sunshine Lake Pharma has a market cap or net worth of 21.05 billion as of September 11, 2026. Its market cap has decreased by -32.22% in one year.
Market Cap
21.05B
Enterprise Value
25.47B
Revenue
4.56B
Ranking
n/a
PE Ratio
n/a
Stock Price
36.96
ChartMarket Cap Chart
Since December 29, 2015, Sunshine Lake Pharma's market cap has increased from 6.55B to 21.05B, an increase of 221.19%. That is a compound annual growth rate of 11.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 21.05B | -19.90% |
| Dec 31, 2025 | 26.27B | 212.32% |
| Dec 31, 2024 | 8.41B | 0.74% |
| Dec 29, 2023 | 8.35B | 46.00% |
| Dec 30, 2022 | 5.72B | 6.56% |
| Dec 31, 2021 | 5.37B | -30.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Simcere Pharmaceutical Group | 29.87B |
| China Resources Pharmaceutical Group | 28.21B |
| China Medical System Holdings | 26.86B |
| Grand Pharmaceutical Group | 17.33B |
| The United Laboratories International Holdings | 16.69B |
| Fujian Haixi Pharmaceuticals | 15.48B |
| CanSino Biologics | 13.47B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |